DelveInsight Evaluates a Robust Antibody-drug Conjugates in Oncology Clinical Trial Pipeline as 30+ Influential Pharma Players to Set Foot in the 7MM
May 01, 2023 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, May 01, 2023 (GLOBE NEWSWIRE) -- DelveInsight Evaluates a Robust Antibody-drug Conjugates in Oncology Clinical Trial Pipeline as 30+ Influential Pharma Players to Set Foot in the 7MM ...